C19H26F3N3O4S — CID 155838272
(5aR,9aR)-8-cyclobutyl-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5a,6,7,9,9a-hexahydro-2H-pyrido[4,3-f][1,4]oxazepin-5-one;2,2,2-trifluoroacetic acid (PubChem CID 155838272) has the molecular formula C19H26F3N3O4S and a molecular weight of 449.50 g/mol. Its IUPAC name is (5aR,9aR)-8-cyclobutyl-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5a,6,7,9,9a-hexahydro-2H-pyrido[4,3-f][1,4]oxazepin-5-one;2,2,2-trifluoroacetic acid.
| Compound Name | (5aR,9aR)-8-cyclobutyl-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5a,6,7,9,9a-hexahydro-2H-pyrido[4,3-f][1,4]oxazepin-5-one;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 155838272 |
| Molecular Formula | C19H26F3N3O4S |
| Molecular Weight | 449.50 g/mol |
| Exact Mass | 449.16 |
| IUPAC Name | (5aR,9aR)-8-cyclobutyl-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5a,6,7,9,9a-hexahydro-2H-pyrido[4,3-f][1,4]oxazepin-5-one;2,2,2-trifluoroacetic acid |
| SMILES | Cc1nc(CN2CCO[C@H]3CN(C4CCC4)CC[C@H]3C2=O)cs1.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C17H25N3O2S.C2HF3O2/c1-12-18-13(11-23-12)9-20-7-8-22-16-10-19(14-3-2-4-14)6-5-15(16)17(20)21;3-2(4,5)1(6)7/h11,14-16H,2-10H2,1H3;(H,6,7)/t15-,16+;/m1./s1 |
| InChIKey | KLPPMRFPTZZMSZ-RCPFAERMSA-N |
| XLogP | 2.69 |
| TPSA | 82.97 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.50 |
| LogP ≤ 5 | 2.69 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |